Zynerba Pharma (ZYNE) Positive ZYN002 Data from STAR 1 and STAR 2 Presented at AES
Tweet Send to a Friend
Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) reported new clinical data presented at the 2017 Annual Meeting of the American Epilepsy Society ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
